The JAK2(V617F) mutation may be present several years before the occurrence of overt myeloproliferative disorders.
Bellanné-Chantelot
C
C
Jego
P
P
Lionne-Huyghe
P
P
Tulliez
M
M
Najman
A
A
D005192:Family Health; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D020125:Mutation, Missense; D009196:Myeloproliferative Disorders / Q000209:etiology*; D013997:Time Factors
D053614:Janus Kinase 2